Quick Answer
TherapeuticsMD, Inc. reported Total Assets of $37.66 million for the year ending 2025.
- TherapeuticsMD, Inc. showed a decrease of -3.0% in Total Assets from 2024 to 2025.
- This data is from TherapeuticsMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2010: $467.4 thousand | Q2 2011: $5.5 thousand | Q3 2011: $7.3 thousand | Q1 2012: $1.49 million | Q2 2012: $4.88 million | Q3 2012: $3.51 million | Q1 2013: $44.19 million | Q2 2013: $43.07 million | Q3 2013: $68.48 million | Q1 2014: $53.57 million | Q2 2014: $44.43 million | Q3 2014: $74.61 million | Q1 2015: $99.48 million | Q2 2015: $75.68 million | Q3 2015: $90.46 million | Q1 2016: $192.97 million | Q2 2016: $176.59 million | Q3 2016: $158.82 million | Q1 2017: $124.42 million | Q2 2017: $106.88 million | Q3 2017: $160.36 million | Q1 2018: $122.96 million | Q2 2018: $171.90 million | Q3 2018: $236.75 million | Q1 2019: $181.89 million | Q2 2019: $246.55 million | Q3 2019: $249.96 million | Q1 2020: $268.64 million | Q2 2020: $205.54 million | Q3 2020: $177.29 million | Q1 2021: $239.31 million | Q2 2021: $210.60 million | Q3 2021: $209.63 million | Q1 2022: $133.38 million | Q2 2022: $146.20 million | Q3 2022: $133.91 million | Q1 2023: $59.60 million | Q2 2023: $53.69 million | Q3 2023: $50.49 million | Q1 2024: $42.09 million | Q2 2024: $40.13 million | Q3 2024: $39.55 million | Q1 2025: $38.24 million | Q2 2025: $38.50 million | Q3 2025: $38.67 million.
- Over the full 15 years of available data (2011 to 2025), TherapeuticsMD, Inc.'s Total Assets has grown by 2,517.3%.
- Historical annual values: Fiscal year 2025: $37.66 million | Fiscal year 2024: $38.82 million | Fiscal year 2023: $43.31 million | Fiscal year 2022: $90.46 million | Fiscal year 2021: $169.47 million | Fiscal year 2020: $181.61 million | Fiscal year 2019: $265.99 million | Fiscal year 2018: $211.98 million | Fiscal year 2017: $143.23 million | Fiscal year 2016: $142.47 million | Fiscal year 2015: $73.73 million | Fiscal year 2014: $59.08 million | Fiscal year 2013: $62.02 million | Fiscal year 2012: $5.93 million | Fiscal year 2011: $1.44 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: